Robert J. Gould, See Remarks at Fulcrum Therapeutics, Inc. (FULC), sold 2,802 shares at $20.00 ($56K) on 2020-06-02, disclosed to the SEC on 2020-06-03.
Open-market sale of $56k FULC by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 5 | $100 | 0.2% |
| 2 | $20.00 | 2,797 | $56K | 99.8% |
| Total | $20.00 avg | 2,802 | $56K | 100% |
| Filing → |
| FULC | SELL | 2026-01-06 | $356K | — | Filing → |
| FULC | SELL | 2025-11-21 | $165K | — | Filing → |
| FULC | SELL | 2023-01-13 | $101K | — | Filing → |